Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

ETHSX vs SCHLX overlap: 70% of top holdings shared

Bottom line

How much do ETHSX and SCHLX overlap?

70% of their top holdings overlap by weight. 16 securities appear in both funds' top 25, making up 72.0% of ETHSX's assets and 62.1% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.

Updated Nov 22, 2026

Overlap at a glance

ETHSXSCHLX
Weight overlap (top 25)70%
Shared holdings16
Weight in shared holdings72.0%62.1%
Total positions4265
Expense ratio1.18%1.06%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings ETHSX and SCHLX have in common

Holding% of ETHSX% of SCHLXOverlap
Eli Lilly & Co12.47%13.85%12.47%
AbbVie Inc6.46%4.90%4.90%
Johnson & Johnson6.45%6.19%6.19%
AstraZeneca PLC6.24%3.80%3.80%
UnitedHealth Group Inc5.49%5.73%5.49%
Roche Holding AG5.44%1.24%1.24%
Merck & Co Inc5.08%4.85%4.85%
Bristol-Myers Squibb Co4.25%1.50%1.50%
Vertex Pharmaceuticals Inc3.38%2.45%2.45%
Gilead Sciences Inc3.34%2.78%2.78%
Thermo Fisher Scientific Inc2.79%3.46%2.79%
Intuitive Surgical Inc2.72%2.69%2.69%
Stryker Corp2.21%2.61%2.21%
Boston Scientific Corp2.18%2.10%2.10%
Medtronic PLC1.80%1.54%1.54%
Abbott Laboratories1.65%2.39%1.65%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in ETHSX

  1. Sanofi SA — 2.95%
  2. Lonza Group AG — 1.77%
  3. Novo Nordisk A/S — 1.71%
  4. Novartis AG — 1.65%
  5. Argenx SE — 1.61%
  6. Royalty Pharma PLC — 1.58%
  7. Neurocrine Biosciences Inc — 1.41%
  8. Mettler-Toledo International Inc — 1.36%
  9. Straumann Holding AG — 1.34%

Only in SCHLX

  1. Novartis AG — 2.90%
  2. Amgen Inc — 2.88%
  3. Danaher Corp — 2.13%
  4. McKesson Corp — 2.05%
  5. Novo Nordisk A/S — 1.73%
  6. Regeneron Pharmaceuticals Inc — 1.43%
  7. Cardinal Health Inc — 1.34%
  8. Cencora Inc — 1.26%
  9. Pfizer Inc — 1.17%

Asset mix

Asset typeETHSXSCHLX
Stocks99.4%99.6%
Cash & short-term funds0.3%0.5%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryETHSXSCHLX
US69.4%85.7%
CH10.2%5.2%
GB7.8%3.8%
FR3.2%1.0%
DK2.9%1.7%
NL2.0%1.0%
IE1.8%1.5%
AU0.9%—

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do ETHSX and SCHLX overlap?
About 70% by weight. 16 securities appear in both funds' top 25 holdings; they make up 72.0% of ETHSX's assets and 62.1% of SCHLX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do ETHSX and SCHLX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, AbbVie Inc, Merck & Co Inc.
Should I own both ETHSX and SCHLX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, ETHSX or SCHLX?
SCHLX is broader, with 65 positions versus 42 for ETHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.